Many seniors are prescribed medications considered high-risk because of their potential to cause adverse reactions and events. The U.S. Food and Drug Administration (FDA) is addressing this issue with its recent release of safety tips for older adults. Health insurers can do even more by implementing a high-risk medication intervention program.
The Pediatric Behavioral Health Medication Initiative (PBHMI), a program developed by UMass Medical School and MassHealth, Massachusetts’ Medicaid program, may help reduce the use of pediatric behavioral medications, according to an article in Managed Healthcare Executive Oct. 29.
Managing pediatric behavioral health medications to ensure safe and effective care will be presented by clinical pharmacists in UMass Medical School’s Commonwealth Medicine division at the Academy of Managed Care Pharmacy’s Nexus conference Oct. 26-29 in Orlando, Florida.